Humanized monoclonal antibody hMN-14 targeted to carcinoembryonic antigen data

IMMU (Morris Plains, N.J.) reported preliminary results in 17 patients, showing no HAMA reaction and comparable targeting to mouse antibody.

As presented at the meeting of the Society of Nuclear Medicine in Minneapolis, the only anti-antibody response to the humanized product occurred in a patient who also had received the murine version. ...